AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure

NEXT STORY
Yale School of Medicine to Present Data on Reversal of Fatty Liver and Plasma Triglycerides in NHPs
PREV STORY
Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TCR² Therapeutics to Host R&D Day on October 20, 2021

author_avatar
NASDAQ Market News

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

author_avatar
NASDAQ Market News

Terveystalo Plc: The Finnish Competition and Consumer Authority initiates further proceedings concerning the transaction between Terveystalo and Attendo

Terveystalo Plc Stock Exchange release 17 July 2018 at 09.00 a.m. EEST Terveystalo Plc ...

author_avatar
NASDAQ Market News